Covidien SM5627 - Suture Biosyn Mono Ud P12 4-0 18" 12/BX
Covidien SM5627 BIOSYN Monofilament Absorbable Suture, Premium Reverse Cutting, Size 4-0, Undyed, 18" Length, Needle P-12, 3/8 Circle (Pack of 12)
Bison synthetic absorbable sutures are prepared from Glomar 631, a synthetic polyester composed of glycoside (60%), diolamine (14%), and trim ethylene carbonate (26%). These sutures are colored violet to increase visibility and are also available undyed. Bison sutures are indicated for use in general soft tissue approximation and/or ligation including use in ophthalmic surgery, but not for use in cardiovascular or neurological surgery.
Premium Reverse Cutting - Biosyn 4-0 Undyed 18" C-12
|Item Number||Structure||Suture Type||Size USP||EP||Length. (CM)||Color||Box Qty|
Excellent Strength and Security
Biosyn monofilament absorbable sutures have the tensile strength needed for the critical wound healing period of about three weeks. Biosyn synthetic sutures are prepared from Gylcomer 631, a synthetic polyester composed of glycolide (60%), dioxanone (14%), and trimethylene carbonate (26%). These sutures are colored violet to increase visibility and are also available undyed. Biosyn sutures are indicated for use in general soft tissue approximation, subcuticular skin closure and/or ligation including use in ophthalmic surgery.
The advanced extrusion process of the molecule of Gylcomer 631 gives the suture:
- Excellent initial strength
- Excellent in-vivo strength over the critical wound healing period
- Excellent knot security
- Minimal memory for handling ease
Biosyn synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation including use in ophthalmic surgery, but not for use in cardiovascular or neurological surgery.
This suture, being absorbable, should not be used where extended approximation of tissue is required.
Synthetic polyester composed of glycolide, dioxanone, and trimethylene carbonate.
Biosyn synthetic absorbable sutures elicit a minimal acute inflammatory reaction in tissues, which is followed by gradual encapsulation of the suture by fibrous connective tissue. Progressive loss of tensile strength and eventual absorption of Biosyn synthetic absorbable sutures occurs by means of hydrolysis where the suture is broken down to glycolic acid, dioxanoic acid, propane diol and carbon dioxide which are subsequently absorbed and metabolized by the body.
Studies in animals indicate tensile strength averages for Biosyn synthetic absorbable sutures are approximately 75% of U.S.P and E.P. minimum knot strength at two weeks and approximately 40% at three weeks post-implant.
- 2 weeks: 75% USP;
- 3 weeks: 40% USP
- Ethylene oxide.
Absorption begins as a loss of tensile strength without appreciable loss of mass. Absorption of Biosyn synthetic absorbable sutures is essentially complete between 90 and 110 days.
Biosyn synthetic absorbable sutures are available undyed (natural) or dyed violet in U.S.P. and E.P. sizes 1 (4 Metric) through 60 (0.7 Metric). The sutures are supplied sterile, in pre-cut lengths or affixed to various needle types using both permanent and removal needle attachment techniques. Please refer to the individual package IFUs for complete instructions, indications, contraindications, warnings and precautions.
|What MRI safety information does the labeling contain?||Labeling does not contain MRI Safety Information|
|Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437):||No|
|Device labeled as "Not made with natural rubber latex":||No|
|Prescription Use (Rx):||Yes|
|Over the Counter (OTC):||No|
|Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P):||No|
Frequently asked questions
Q: Biosyn suture "spits" more than Monocryl?
A: Monocryl* is fully absorbed in 91 - 119 days, whereas Biosyn suture is fully absorbed in 90 - 110 days.
Q: Biosyn suture breaks when repositioned?
A: With Biosyn suture, theres no need to reposition the throw. Just run down the knot and the step is finished.
Q: What is the corresponding suture in the Ethicon portfolio?